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Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis
Authors:
Jason D. Coombes 1, 2 , Steve S. Choi 3, 4 , Marzena Swiderska-Syn Liver fibrosis develops when hepatic stellate cells (HSC) are activated into collagenproducing myofibroblasts. In non-alcoholic steatohepatitis (NASH), the adipokine leptin is upregulated, and promotes liver fibrosis by directly activating HSC via the hedgehog pathway. We reported that hedgehog-regulated osteopontin (OPN) plays a key role in promoting liver fibrosis. Herein, we evaluated if OPN mediates leptinprofibrogenic effects in NASH.
Methods:
Leptin-deficient (ob/ob) and wild-type (WT) mice were fed control or methioninecholine deficient (MCD) diet. Liver tissues were assessed by sirius-red, OPN and SMA IHC, and qRT-PCR for fibrogenic genes. In vitro, HSC with stable OPN (or control) knockdown were treated with recombinant (r)leptin and OPN-neutralizing or sham-aptamers. HSC response to OPN loss was assessed by wound healing assay.
OPN-aptamers were also added to precision-cut liver slices (PCLS), and administered to MCD-fed WT (leptin-intact) mice to determine if OPN neutralization abrogated fibrogenesis.
Results:
MCD-fed WT mice developed NASH-fibrosis, upregulated OPN, and accumulated SMA+ cells. Conversely, MCD-fed ob/ob mice developed less fibrosis and accumulated fewer SMA+ and OPN+ cells. In vitro, leptin-treated HSC upregulated OPN, SMA, collagen  and TGF mRNA by nearly 3-fold, but this effect was blunted by OPN loss. Inhibition of PI3K and transduction of dominant negative-Akt
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6 abrogated leptin-mediated OPN induction, while constitutive active-Akt upregulated OPN. Finally, OPN neutralization reduced leptin-mediated fibrogenesis in both PCLS and MCD-fed mice.
Conclusion
OPN overexpression in NASH enhances leptin-mediated fibrogenesis via PI3K/Akt.
OPN neutralization significantly reduces NASH fibrosis, reinforcing the potential utility of targeting OPN in the treatment of patients with advanced NASH.
Introduction
Individuals with nonalcoholic steatohepatitis (NASH), an advanced stage of nonalcoholic fatty liver disease (NAFLD), are at risk of disease progression that leads to liver fibrosis, cirrhosis, and cancer (1 -4). The mechanisms which drive NASH progression are not entirely understood, but studies suggest that liver cell injury from lipotoxicity and oxidative stress triggers a fibrogenic repair response.
Liver fibrosis develops when this injury-associated repair response becomes excessive or deregulated (5 -6).
The hepatic stellate cell (HSC) or liver pericyte is the major source of extracellular matrix, and thus, the key effector of the repair response (7) . When activated by cytokines (transforming growth factor ), growth factors (connective tissue growth factor), or morphogens (hedgehog (Hh), Wnt), quiescent HSC transition into motile, collagen-secreting myofibroblasts (8) . HSCs are also capable of responding to circulating neurotransmitters and hormones (9, 10) . Leptin is an adipocyte-derived hormone which, not only controls energy balance and food intake, but also modulates the liver repair response (11 -13) . Binding of leptin to HSC surface receptors for instance, upregulates key fibrogenic genes SMA and collagen 11, while mice deficient in leptin (i.e. ob/ob mice) are protected against liver fibrosis (11, 14, 15) . In humans, serum and tissue leptin levels are highly elevated in the obese (16 -18) , helping to explain at least in part, why obese, NAFLD individuals are more at risk of developing liver fibrosis.
Recently, we reported that leptin-induced liver fibrosis occurs via activation of the Hh pathway (19) (a key morphogenic signal that regulates development as well A C C E P T E D M A N U S C R I P T 
Rat HSC isolation
Primary HSCs were isolated from Sprague-Dawley rats, assessed for purity and viability, and seeded at a density of 3 x 10 2 cells/mm 2 in DMEM supplemented with 10% fetal bovine serum (FBS) and penicillin (50 U/ml) /streptomycin (50 ug/ml) (20) . For studies that involved treatments with leptin (100ng/ml; R&D systems, Minneapolis, MN) and/or adenoviral vectors, day 7 HSC cultures were cultured overnight in serum-depleted medium (0.1% FBS) before treatments were initiated.
Adenoviral Transduction of Primary Rat HSC
Ad5GFP, which contains the GFP gene driven by the cytomegalovirus promoter, was used as a control virus. The Ad5dnAkt and Ad5myrAkt viruses express the dominant negative and activated forms of Akt, respectively (19) . Pilot studies demonstrated that maximally efficient transduction occurred at a multiplicity
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of infection of 100. Subsequent experiments were carried out with this multiplicity of infection for 24 h; virus-containing medium was then aspirated and replaced with fresh medium.
HSC line and treatments
The mouse HSC line (GRX) was maintained in DMEM, 5% FBS, and 1% penicillin/streptomycin as described (27) . Cells were treated with recombinant leptin 
Semi-quantitative real-time PCR
Total RNA was extracted from cell cultures using TRIzol® (Life Technologies, Carlsbad, CA) according to manufacturer's instructions. RNA (1 µg) was reverse transcribed to cDNA templates using iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). For semiquantitative RT-PCR, cDNA (25 ng) was amplified using SYBR® Green PCR Master Mix (Life Technologies) and oligonucleotide primers for specific targets sequences on an Applied Biosystems 7500 Real-Time PCR system. RT-PCR parameters were as follows: denaturating at 95°C for 10 minutes, followed by 40 protein of ATP measured 2h after recovery (i.e. time 0h in Fig 5A) .
Statistical Analysis
Results are expressed as means ± SEM. Significance was established using the Student's t-test and analysis of variance. Differences were considered significant when p < 0.05.
Results
Leptin-deficient (ob/ob) livers contain less Osteopontin and are less fibrotic than control (WT) livers after MCD treatment
Chronic exposure to the MCD diet induced comparable epithelial cell injury in WT (leptin-intact) and ob/ob (leptin-deficient) mice (28, 29) . WT mice developed significant liver fibrosis in response to the MCD diet, as evidenced by ~6-fold accumulation of Sirius red stained collagen fibrils (Suppl Fig 1A -C) , ~2.5-fold increase in hepatic hydroxyproline content (Suppl Fig 1D) , and a 4-fold upregulation in collagen 11 mRNA (Suppl Fig 1E) . Collagen deposition was accompanied by the accumulation of SMA+ cells ( Suppl Fig 2A -B) , OPN+ cells (Fig 1A-B) , and induction of key fibrogenic genes, SMA (~4-fold) (Suppl Fig 2C) , TGF-1 (~3-fold)(Suppl Fig 2D) , and OPN (greater than 10-fold) (Fig 1C) .
By contrast, fibrosis was significantly less in ob/ob mouse livers after the MCD diet ( Suppl Fig 1) : ob/ob livers contained nearly 50% fewer Sirius red stained collagen fibrils (Suppl Fig 1A -C) , ~2.5-fold less liver hydroxyproline (Suppl Fig   1D) , ~50% less TGF-1 mRNA, and exhibited minimal induction of collagen 11, SMA and OPN mRNA (Suppl Fig 1E, 2C, 2D, and Fig 1C) . The degree of weight loss however, was similar between (WT and ob/ob) MCD-fed groups. These findings confirm that leptin directly promotes fibrogenesis in MCD-induced NASH (11, 19, 28) .
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OPN is a downstream effector of Leptin in Hepatic Stellate Cells (HSC)
Leptin is a pro-fibrogenic adipokine which directly activates HSC, the liver pericyte responsible for collagen matrix deposition during chronic injury (11, 12) .
Recently, we reported that OPN, a matrix protein and cytokine, could also promote HSC activation (23, 24) . In this study, the loss of circulating leptin was directly associated with repressed liver OPN (Fig 1) , and attenuated liver fibrogenesis ( Suppl Fig 1, 2) . These observations led us to hypothesize that leptin could regulate OPN expression in HSC.
Recent studies revealed that HSC isolated from livers subjected to biliary or chemical injury upregulated OPN mRNA (Suppl Fig 3) (30) . In support, we confirmed by double immunohistochemistry that desmin (+) HSC co-expressed OPN (Fig 1D) . Importantly, the number of desmin / OPN double (+) HSC accumulated by more than 5-fold in MCD-fed mice, but this increase was almost abolished in ob/ob-MCD mice.
To determine if leptin was directly influencing OPN expression in HSC, we treated the mouse HSC line, GRX, with recombinant leptin (rleptin) for 48 h; cells were then harvested for RNA analysis by qRTPCR. rLeptin activated HSC ( Suppl   Fig 4) , upregulated OPN, and key fibrogenic markers, SMA, collagen 11, TGF (~2-fold) (Fig 2A -D) . We next investigated if loss of OPN would inhibit leptin fibrogenic effects. To this end, GRX were treated with lentiviral particles which containin shRNA constructs specifically targeting OPN (GRX-shOPN). Compared with control (GRX-shScr) (GRX infected with lentiviral particles containing nontargeting scrambled shRNA), OPN knockdown (~80%) (Suppl Fig 5) significantly
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16 abrogated leptin fibrogenic effects by >90% (Fig 2) . As increased cell migration is an important feature of activated HSC, we further examined if OPN knockdown (under leptin-stimulated conditions) would impair HSC migratory properties. Migration was assessed by semi-quantitating the dimensions of a wound dividing the confluent monolayer 12 h after the scratch. OPN knockdown led to ~15% less wound healing compared with controls (p<0.05) (Fig 2E) . Comparable results observed in the modified cell-invasion assay (Fig 2F) . OPN knockdown led to 50% fewer GRX cells invading across the insert membrane.
We verified these results using OPN-specific aptamers which neutralize circulating OPN (25, 26) , in the presence of rleptin. OPN neutralization blunted SMA expression (Suppl Fig 6A) , and significantly repressed collagen 11 and TGFmRNA (~50%) (Suppl Fig 6B -C) . Similar to knockdown experiments, OPN neutralization also inhibited migratory properties of HSC, leading to impaired wound healing (~30%) and transmigration (~50%) across membranes (Suppl Fig 6D-E) . In aggregate, these results demonstrate that OPN is a downstream effector of leptininduced fibrogenesis, and that OPN is a potential anti-fibrotic target.
OPN expression is regulated by Leptin-PI3K/Akt signaling in HSC
Leptin receptors couple with PI3K and activate Akt, which is required for leptin-associated fibrogenic effects (31, 32) . Leptin activates the hedgehog (Hh) pathway (an important morphogenic pathway during development and adult fibrogenesis) in HSC, but this is blocked by LY294002, a PI3K inhibitor (19) .
Because OPN is a downstream target of the Hh pathway (24), we investigated if OPN could similarly be regulated by the PI3K/Akt pathway. GRX HSCs were treated
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with leptin in the presence or absence of LY294002. LY294002 significantly repressed OPN mRNA by >50% (Fig 3A) , and downregulated fibrogenic genes SMA, collagen 11, and TGFby up to 60% (Fig 3B-D) . OPN knockdown in combination with LY294002 further enhanced repression of fibrogenic genes by an additional ~20% (Fig 3) .
To exclude the possibility that observed responses were GRX-specific, we repeated experiments using freshly isolated rat HSC. Comparable with GRX HSCs, leptin-treated, primary rat HSC upregulated OPN, SMA, and collagen 11 mRNA by ~2-fold (Fig 4A-C) , but this effect was completely blocked in the presence of LY294002. OPN mRNA in particular, was repressed below basal expression.
Adenoviral-mediated transfer of dominant negative Akt (dnAkt) similarly inhibited leptin-mediated changes in OPN, SMA, and collagen 11 mRNA (Fig 4A-C and collagen 11 mRNA to levels comparable with leptin-treated cells (Fig 4) .
Previous studies suggested that leptin-mediated induction of the JAK/STAT pathway influences HSC fibrogenesis (11, 23) . To clarify the role of leptin-mediated JAK/STAT signaling in modulating OPN expression, primary rat HSC were also treated with leptin in the presence or absence of AG490 (an inhibitor of JAK signaling). Compared with DMSO control, pre-treatment with AG490 inhibited OPN mRNA by ~30%.However this effect was significantly less pronounced than LY294002 treatment (Suppl Fig 7) . These data in aggregate confirm that OPN expression in HSC is predominantly leptin-PI3K/Akt-regulated.
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OPN neutralization inhibits leptin-associated fibrogenesis in precision-cut liver slices (PCLS) and in a mouse model of diet-induced NASH
To validate in vitro findings, we used an established liver organ culture system in which precision-cut, viable mouse liver slices (PCLS) were stimulated with leptin, in the presence of sham-or OPN-specific aptamers. PCLS are useful because they can be cultured for several days and better reflect the multicellular in vivo conditions (33, 34) . Liver slice viability was maintained as evidenced by the MTT assay ( Fig   5A) . Treatment with exogenous leptin upregulated liver slices OPN mRNA by ~2-folds (Fig 5B) , and induced SMA and collagen 11mRNA by ~20% (Fig 5C-D) .
Conversely, neutralizing OPN significantly repressed OPN and collagen 11mRNA, even beyond basal levels. No change in total slice SMA mRNA was detected.
Having demonstrated that OPN is the downstream, fibrogenic effector of leptin, we evaluated the impact of OPN neutralization in MCD-fed, leptin-intact (i.e.
WT) mice. MCD-fed mice were administered sham-aptamers or OPN-specific aptamers via tail-vein for 2 weeks. At the end of treatment, livers were harvested and fibrosis assessed by qRTPCR and IHC. As expected, mice developed NASH-fibrosis after 5 weeks of the MCD diet (Fig 6 and Suppl Fig 1A) (23, 24) . Consistent with cell culture and PCLS findings, OPN neutralization significantly reduced MCD dietinduced fibrosis, as evidenced by fewer Sirius-Red stained collagen fibrils (Fig 6A -B ), attenuated expression of fibrogenic genes, SMA, collagen 11 (Fig 6C-D) , and reduced liver OPN expression (Fig 6E-F) .
Discussion:
Our study confirms that OPN is a key driver of HSC activation, and is an (5, 36) . In the liver, we and others recently reported that over-activation of the Hh pathway occurs during human NASH progression (37, 38) , and that blocking Hh with the commercially available inhibitor, GDC0449 or cyclopamine ameliorates NASH and reduces liver fibrosis in mice (37, 38) .
The role of OPN in liver inflammation and fibrosis is complex, and has only begun to be unravelled. Outside of the liver, OPN appears to exhibit fairly divergent roles in acute and chronic diseases. In allergic airway disease, OPN is proinflammatory during primary systemic sensitization, but anti-inflammatory during Leptin is an adipose tissue-derived hormone whose physiological role is to induce satiety, but levels of leptin are significantly higher in the obese, and in some with NAFLD (16, 17) . To date, studies have evaluated the potential utility of leptin replacement in those with hypoleptinemia-NASH. In one study, leptin administration improved steatosis, but not fibrosis stage (44) , and as leptin is directly pro-fibrogenic, it is possible that supplementation of exogenous leptin may inadvertently lead to worsening fibrosis. On the other hand, leptin-neutralization in those with advanced NASH-fibrosis (and excess leptin) may be a useful anti-fibrotic strategy (as observed in our study), although the likely increase in food intake and body weight (and metabolic risk) may well cancel out any potential clinical benefit.
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Like leptin, plasma OPN levels are increased in the obese and in patients with type 2 diabetes mellitus, hypertension, and ischemic heart disease (45). More recently, serum OPN was also found to be associated with the onset of diabetic nephropathy and cardiac events (46) . Thus, high levels of OPN occur in those with the metabolic syndrome, a risk factor for progressive NASH. Importantly, OPN neutralization reduces infiltration of macrophages and immune subsets into adipose tissues, reduces obesity-induced inflammation, and improves systemic glucose tolerance (47 -50) . In concert with the current findings, these data suggest that OPN could be an important target in the treatment of obese patients with NASH (and the metabolic syndrome), by reducing insulin resistance and limiting NASH-fibrosis (in spite of high prevailing leptin levels).
In summary, our analyses in cell-culture and mice show that OPN is leptin- 
